No Clinically Significant Interaction Between Tamsulosin and Perindopril
There is no clinically significant interaction between tamsulosin and perindopril that would preclude their concurrent use in most patients. Both medications can be safely administered together in patients requiring treatment for both hypertension and benign prostatic hyperplasia (BPH).
Mechanism of Action and Selectivity
Tamsulosin
- Selective alpha-1A and alpha-1D adrenergic receptor antagonist
- Primarily targets receptors in the prostate gland, prostatic capsule, prostatic urethra, and bladder 1
- Standard dosing: 0.4 mg once daily in a modified-release formulation
- Unlike non-selective alpha blockers (doxazosin, terazosin), tamsulosin has minimal effect on blood pressure due to its receptor selectivity
Perindopril
- Angiotensin-converting enzyme (ACE) inhibitor used for hypertension management
- Prodrug that is hydrolyzed to the active metabolite perindoprilat 2
- Standard dosing: 4-16 mg once daily 3
- Provides 24-hour ACE inhibition with once-daily dosing
Evidence for Safety of Concurrent Use
Tamsulosin was specifically designed to minimize cardiovascular effects compared to other alpha blockers. A key study notes that tamsulosin "does not interfere with concomitant antihypertensive therapy" and "has not been associated with clinically significant changes in blood pressure in clinical trials" 1.
Research specifically examining hypertension management in elderly patients with coexisting BPH found that "there appears to be no adverse interaction with any other antihypertensive medication" when using tamsulosin 4. This contrasts with non-selective alpha blockers like doxazosin or terazosin, which can cause additive blood pressure lowering effects.
Potential Concerns
While the medications generally don't have significant interactions, caution may be warranted in:
- Elderly patients - May have increased sensitivity to blood pressure-lowering effects
- Patients with orthostatic hypotension - One case report described pronounced hypotension during orthostatic testing in a patient taking both sildenafil and tamsulosin 5, suggesting that some individuals may be more susceptible to hypotensive effects
Clinical Recommendations
- No dosage adjustment is typically needed when combining tamsulosin and perindopril
- Monitor blood pressure after initiating therapy, particularly in elderly patients
- Advise patients about potential symptoms of hypotension (dizziness, lightheadedness) and to report these if they occur
- If hypotensive symptoms develop, consider:
- Taking medications at different times of day
- Adjusting the dose of perindopril while maintaining the standard tamsulosin dose
- Evaluating for other contributing factors (dehydration, other medications)
Conclusion
Tamsulosin's uroselective properties make it an ideal alpha blocker for patients with both hypertension and BPH, as it does not significantly affect blood pressure control achieved with antihypertensive medications like perindopril. The combination is generally safe and effective for managing both conditions simultaneously.